A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
about
Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical ProstatectomyAssociation between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical ProstatectomyTri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial.Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database.Surgery for high-risk localized prostate cancer.Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH databaseManagement of high-risk localized prostate cancer.Active surveillance for low-risk prostate cancer.Radical prostatectomy with positive surgical margins: how are patients managed?Nomograms for prostate cancer.Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP databaseValidation of Selection Criteria for Active Surveillance in Prostate Cancer.Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens.Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.Dynamic prediction of metastases after radical prostatectomy for prostate cancer.International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes.Formalized prediction of clinically significant prostate cancer: is it possible?Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml.The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.Prediction of biochemical failure in localized carcinoma of prostate after radical prostatectomy by neuro-fuzzy.Limiting overdiagnosis of low-risk prostate cancer through an evaluation of the predictive value of transrectal and power Doppler ultrasonography.sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience.Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6.The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy.Clinical and pathologic factors predicting reclassification in active surveillance cohorts.
P2860
Q28552107-8ADB4B89-25BE-4DD7-94BF-9888D5BAE6B5Q28553140-0894C1D3-D8DB-49C1-8035-2DECB85E890DQ34206798-0F520D9C-9A11-422E-AF59-EB815F194662Q35217844-483E7AC7-2AD0-4E75-B78C-9D55F043A565Q35220192-37961DF6-07E0-4D38-8EA8-82FE5A2D9540Q35231112-54772D34-23EA-482E-9D11-3EAB05D7DC80Q35503645-282EB063-F64B-420A-B675-155FE9E5ECB1Q36141777-E8255615-92A6-4A8D-BE37-AA0745A0965DQ36392162-B13B52A4-15A0-4245-A583-54FA96C4E21FQ36532217-F3615C91-256B-4ADA-B307-F0D086E83280Q36563715-AC67710A-F984-42CA-83B9-E012E11785D9Q36870722-89C44A0D-A7D8-47EA-9061-E3EDD9E25ED3Q36898971-5F80CB1B-2926-4C2C-99AB-589670E7EA73Q36906894-093A82E2-0BF2-4F3F-A21A-5F3DDF1AD036Q37331924-AF5005AB-5D7C-4EEA-86CE-28A8B3F5AE4AQ37637096-ABB1EF3C-5704-4FD8-943D-F4C409020593Q37785485-96EEADA1-101F-48AF-936C-6835749B4E70Q37988363-3FF4215A-6D36-4ED0-A40A-2F33049FBA52Q38466827-534FC62A-E024-4B2A-9CC7-ABCE652E54ECQ38792226-25316578-3B78-4FB9-AEEA-7368D311F853Q39213559-73CFDF0A-2980-4BAF-A6D8-5C7DB3CC7723Q39896736-152D19FB-8133-4237-B3FB-8CF049C43294Q40428138-9BB8AFF6-F959-416C-A7A1-3C684C20EC2FQ41450346-00996A23-B74D-465B-AD48-E83A9A1B2F98Q41566025-8E549E99-02B4-4422-8EDA-6A0A608250DCQ41863428-B4132E28-4ED2-45EF-A9A6-A65016EF5230Q41948740-1ABD3080-DAB2-4106-9006-92592F22FA02Q45990993-1D6614A2-0EA2-48C3-AFFB-5536F4C93C55Q49715354-005FE82A-291B-4950-9258-03B9222ECEE1
P2860
A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
A multivariate analysis of cli ...... tatectomy for prostate cancer.
@en
type
label
A multivariate analysis of cli ...... tatectomy for prostate cancer.
@en
prefLabel
A multivariate analysis of cli ...... tatectomy for prostate cancer.
@en
P2093
P1476
A multivariate analysis of cli ...... tatectomy for prostate cancer.
@en
P2093
D'Amico AV
Malkowicz SB
Tomaszewski JE
Whittington R
P304
P356
10.1097/00005392-199507000-00044
P407
P577
1995-07-01T00:00:00Z